Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient insights following use of LEO 90100 aerosol foam and Daivobet gel in psoriasis vulgaris
2014-003072-24Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of calcipotriol + betamethasone in plaque psoriasis (2 arms), sponsored by LEO Pharma. Primary endpoints: Within-subject difference in response to TPUQ items between trial treatments and Within-subject difference in response to VPM items between trial treatments. Started Nov 2014; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2014-003072-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003072-24.